Glaukos Corporation to Release Fourth Quarter and Full Year 2016 Financial Results after Market Close on March 1

SAN CLEMENTE, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma, plans to release fourth quarter and full year 2016 financial results after the market close on Wednesday, March 1, 2017. The company’s management will discuss the results during a conference call and simultaneous webcast at 1:30 p.m. PST (4:30 p.m